Astera Labs trust sells 136,974 shares under 10b5-1
Astera Labs director-related trust reports pre-planned stock sales.
Rhea-AI Filing Summary
Astera Labs director-related trust reports pre-planned stock sales. Alba 2003 Living Trust, associated with director Manuel Alba, sold a total of 136,974 shares of Astera Labs common stock on July 1, 2026 in multiple open-market transactions under a pre-arranged Rule 10b5-1 trading plan.
The reported sale prices ranged from $429.11 to $459.44 per share, based on weighted-average pricing disclosures. Following these transactions, the trust continues to hold 1,287,524 shares of Astera Labs common stock indirectly for the benefit of the Alba 2003 Living Trust, with Manuel Alba-Marquez and his spouse as co-trustees, and Manuel Alba disclaiming beneficial ownership except to the extent of any pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 5,837 | $429.578 | $2.51M |
| Sale | Common Stock | 30,141 | $430.7907 | $12.98M |
| Sale | Common Stock | 3,485 | $432.7916 | $1.51M |
| Sale | Common Stock | 1,574 | $433.4284 | $682K |
| Sale | Common Stock | 2,279 | $434.7826 | $991K |
| Sale | Common Stock | 2,122 | $435.7564 | $925K |
| Sale | Common Stock | 3,655 | $436.8206 | $1.60M |
| Sale | Common Stock | 2,129 | $437.9323 | $932K |
| Sale | Common Stock | 2,955 | $438.7869 | $1.30M |
| Sale | Common Stock | 4,332 | $440.0528 | $1.91M |
| Sale | Common Stock | 6,904 | $440.8574 | $3.04M |
| Sale | Common Stock | 4,468 | $441.7946 | $1.97M |
| Sale | Common Stock | 4,980 | $442.8711 | $2.21M |
| Sale | Common Stock | 5,437 | $443.8246 | $2.41M |
| Sale | Common Stock | 6,048 | $444.9077 | $2.69M |
| Sale | Common Stock | 4,310 | $445.8516 | $1.92M |
| Sale | Common Stock | 4,082 | $446.9137 | $1.82M |
| Sale | Common Stock | 4,013 | $447.8613 | $1.80M |
| Sale | Common Stock | 6,723 | $448.8474 | $3.02M |
| Sale | Common Stock | 2,586 | $449.8883 | $1.16M |
| Sale | Common Stock | 3,338 | $450.9435 | $1.51M |
| Sale | Common Stock | 4,418 | $451.9576 | $2.00M |
| Sale | Common Stock | 1,204 | $453.1214 | $546K |
| Sale | Common Stock | 1,980 | $453.8275 | $899K |
| Sale | Common Stock | 3,269 | $454.9207 | $1.49M |
| Sale | Common Stock | 2,898 | $455.8879 | $1.32M |
| Sale | Common Stock | 3,396 | $456.9729 | $1.55M |
| Sale | Common Stock | 4,574 | $457.9988 | $2.09M |
| Sale | Common Stock | 3,837 | $459.0178 | $1.76M |
Footnotes (31)
- F1. The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2025.
- F2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $429.1100 to $430.0700, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3. These shares are owned directly by Manuel Alba-Marquez in trust for Alba 2003 Living Trust (the "Alba Trust"), of which the Reporting Person and his spouse are co-trustees. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- F4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $430.1100 to $430.9300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F5. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $432.1800 to $433.1400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F6. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $433.2300 to $433.5600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F7. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $434.2800 to $435.2500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F8. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $435.3200 to $436.3100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F9. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $436.3300 to $437.3100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F10. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $437.3300 to $438.3200, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F11. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $438.3300 to $439.3200, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F12. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $439.3600 to $440.3500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F13. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $440.3600 to $441.3500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F14. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $441.3600 to $442.3500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F15. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $442.3600 to $443.3500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F16. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $443.3600 to $444.3500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F17. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $444.3600 to $445.3500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F18. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $445.3600 to $446.3500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F19. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $446.3600 to $447.3500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F20. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $447.3600 to $448.3500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F21. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $448.3600 to $449.3300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F22. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $449.4200 to $450.4000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F23. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $450.4600 to $451.4500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F24. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $451.4600 to $452.4500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F25. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $452.4600 to $453.4400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F26. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $453.4900 to $454.4700, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F27. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $454.5000 to $455.4700, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F28. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $455.5000 to $456.4700, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F29. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $456.5000 to $457.4600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F30. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $457.5100 to $458.5000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F31. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $458.5100 to $459.4400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
weighted average price financial
beneficial ownership regulatory
pecuniary interest financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Astera Labs (ALAB) insider Manuel Alba report in this Form 4?
Were the Astera Labs (ALAB) insider sales made under a Rule 10b5-1 plan?
What type of transactions were reported for Astera Labs (ALAB) in this Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.